BioSpace News Archive

Study results to be presented at NASPGHAN demonstrate that pediatric patients can grow and thrive on plant-based nutrition delivered orally or through tube feeding

Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of October 2019, representing $0.936 per Common Share on an annualized basis.

Aging US Population Will Drive Increases

Jennifer Bires MSW, LICSW, OSW-C, joins the Inova Schar Cancer Institute, a state-of-the-art cancer care destination in the D.C. Metro area, as the Executive Director of its nationally recognized Life with Cancer and Patient Experience programs.

For the first time, the American Lung Association, the American Diabetes Association (ADA), and the American Heart Association (AHA) have come together to raise an important alert about the dangers of influenza (flu) for people with chronic health conditions, including diabetes, heart disease and lung diseases such as asthma and COPD

MHK (formerly MedHOK), part of the Hearst Health network, announced today the launch of the next version of its CareProminence SaaS platform, introducing new features and functionality to help managed care organizations meet changing regulatory requirements, streamline operations, enhance user productivity, and improve member care.

The AMN Healthcare Team Hope Mission to Guatemala, which provides life-changing and sustainable assistance to people in the country’s impoverished highlands, has been awarded the American Staffing Association’s top Care Award for exceptional corporate social responsibility.

Aro Biotherapeutics Company announces that co-founder and Chief Scientific Officer Karyn O’Neil, PhD, debuted ABX300, the company’s lead Centyrin™-pan-KRAS siRNA program, during a presentation today at the 2019 Oligonucleotide Therapeutic Society (OTS) meeting in Munich, Germany.

Members of Manhattan-based fertility center Reproductive Medicine Associates of New York (RMA of New York) presented 31 scientific abstracts at the 75th annual meeting of the American Society for Reproductive Medicine (ASRM) in Philadelphia, Pennsylvania

Cerevance, a clinical stage biopharmaceutical company advancing new medicines for brain diseases, today announced that Brad Margus, Chief Executive Officer, will present the company’s target discovery and clinical development work during the 2019 BIO Investor Forum taking place October 22nd-23rd, 2019 in San Francisco, CA.